Less known, though they should be, are underrated later gems like 1976's Thirty Three & 1/3 and Harrison's self-titled 1979 ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...